Navigation Links
Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
Date:1/22/2008

ore information on Welchol, call 877-4-DSPROD (877-431-7763), or go to the Welchol web site at http://www.Welchol.com.

About Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc., headquartered in Parsippany, New Jersey, is the U.S. subsidiary of Daiichi Sankyo Co., Ltd., Japan's second largest pharmaceutical company and a global leader in pharmaceutical innovation since 1899. The company is dedicated to the discovery, development and commercialization of innovative medicines that improve the lives of patients throughout the world.

The primary focus of Daiichi Sankyo's research and development is cardiovascular disease, including therapies for dyslipidemia, hypertension, diabetes, and acute coronary syndrome. The company is also pursuing the discovery of new medicines in the areas of glucose metabolic disorders, infectious diseases, cancer, bone and joint diseases, and immune disorders. For more information, please visit http://www.dsus.com.

Please see package insert for full prescribing information.

(1) American Diabetes Association, Diabetes Statistics.

http://www.diabetes.org/diabetes-statistics/prevalence.jsp. Accessed

August 16, 2007.

(2) 2004 National Healthcare Quality Report, Agency for Healthcare,

Research and Quality. United States Department of Health and Human

Services.

(3) Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke

statistics--2007 update: a report from the American Heart Association

Statistics Committee and Stroke Statistics Subcommittee. Circulation.

Feb 6, 2007;115(5):e69-171

(4) American Diabetes Association: Standards of medical care in diabetes

- 2006. Diabetes Care 29(Suppl 1):S4-S42,2006

(5) Grund
'/>"/>

SOURCE Daiichi Sankyo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

4

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
5. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
6. CryoCor Receives FDA Approval for Right Atrial Flutter
7. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
8. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
9. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
10. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
11. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)..., FollowingtheFDAapprovalsoftwonewtherapiesforN...havebeenupdatedtoincludeofatumumab(Azerra(TM),Glax...lymphocyticleukemia(CLL)andromidepsin(Istodax(R),G...atientswithcutaneousT-celllymphoma(CTCL). ,, FO...orecentFDAapprovalshavepromptedtheNationalComprehe...
(Date:11/23/2009)..., NEWYORK,Nov.23/PRNewswire/--Reportlinker.coma...tscatalogue. ,, AnesthesiaDisposables-AWorldMa...164276/Anesthesia-Disposables---A-World-Market-Rev...mp;utm_campaign=prnewswire ,, Globalgeneral...egreeofsaturation.Despitetheconsiderablerisewitnes...
(Date:11/23/2009)..., THEWOODLANDS,Texas,Nov.23/PRNewswire-FirstCal...nnouncedtodaythattop-linedatafromitsPhase2clinical...itablebowelsyndrome(IBS)willbepresentedatGASTRO200...significantimprovementinIBSsymptoms,willbepresente...ofclinicaldevelopment,onNovember25,2009at2:30pmloc...
Breaking Medicine Technology:NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 2NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 3Reportlinker Adds Anesthesia Disposables - A World Market Review 2Reportlinker Adds Anesthesia Disposables - A World Market Review 3Reportlinker Adds Anesthesia Disposables - A World Market Review 4Reportlinker Adds Anesthesia Disposables - A World Market Review 5Reportlinker Adds Anesthesia Disposables - A World Market Review 6Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 3Deere 26amp 3B Company Pleased With Court Ruling Concerning Retiree Health Care 59682 1Deere 26amp 3B Company Pleased With Court Ruling Concerning Retiree Health Care 59682 2Cellu Tissue Holdings Inc Files Registration Statement for Proposed Initial Public Offering of Common Stock 14515 1Cellu Tissue Holdings Inc Files Registration Statement for Proposed Initial Public Offering of Common Stock 14515 2FDA Approves Elitek 28R 29 28rasburicase 29 for Management of Plasma Uric Acid Levels in Adults with Leukemia Lymphoma and Solid Tumors Receiving A 5545 1FDA Approves Elitek 28R 29 28rasburicase 29 for Management of Plasma Uric Acid Levels in Adults with Leukemia Lymphoma and Solid Tumors Receiving A 5545 2FDA Approves Elitek 28R 29 28rasburicase 29 for Management of Plasma Uric Acid Levels in Adults with Leukemia Lymphoma and Solid Tumors Receiving A 5545 3FDA Approves Elitek 28R 29 28rasburicase 29 for Management of Plasma Uric Acid Levels in Adults with Leukemia Lymphoma and Solid Tumors Receiving A 5545 4FDA Approves Elitek 28R 29 28rasburicase 29 for Management of Plasma Uric Acid Levels in Adults with Leukemia Lymphoma and Solid Tumors Receiving A 5545 5FDA Approves Elitek 28R 29 28rasburicase 29 for Management of Plasma Uric Acid Levels in Adults with Leukemia Lymphoma and Solid Tumors Receiving A 5545 6FDA Approves Elitek 28R 29 28rasburicase 29 for Management of Plasma Uric Acid Levels in Adults with Leukemia Lymphoma and Solid Tumors Receiving A 5545 7
(Date:11/23/2009)...idualsintheRecommendedPriorityGroups ,, HARRISB...mentofHealthannouncedtodaytheywillconductthreeaddi...ersinDelaware,Lancaster,andLehighcountiesonTuesday...ministeredforfreetoindividualsintherecommendedtarg...hedepartmentasksthatonlyindividualsinthefollowingg...
(Date:11/23/2009)...n who don,t access health care from the same place...more likely to have unmet health care needs compar...ed in the journal Pediatrics . , Studies like ...livery of quality health care for children, the re...tes about health insurance reform, much of the foc...
(Date:11/23/2009)...mo deal with insomnia, study shows , , M...eep disorders affect more than three-quarters of c...rly three times higher than that of the general po...ore common in younger patients and in those with l...er Medical Center researchers, who assessed sleep ...
(Date:11/23/2009)...ksin Washington D.C. , NewYorkCity , LosAn...micGrowthandRevitalization ,, WASHINGTON,Nov.2...adingproviderofdialysisservices,todaywaslaudedbyD....millioninvestmentinIndustrialBankaspartofaninitiat...Vita,sinvestmentinWashington,D.C.ispartofthedialys...
(Date:11/23/2009)...mSupportsFutureLeadersinSTEMFields ,, Scholar...n ceS c holars.org ,, WASHINGTON,No...ountusin.Withourcommunity,foundation,andcorporatep...ate,"saidAdolphP.Falcon,SeniorVicePresidentoftheNa...teHousemeetingtodaywherePresidentObamaannouncedthe...
Breaking Medicine News(10 mins):Health News:Pennsylvania Department of Health Announces Additional H1N1 Vaccination Clinics in Delaware, Lancaster, Lehigh Counties 2Health News:Children who lack continuity with a regular health care provider miss needed services 2Health News:Children who lack continuity with a regular health care provider miss needed services 3Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 2Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 3Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 4Health News:Alliance Joins President Obama at White House in Commitment to Science, Technology, Engineering, and Math (STEM) Education 2
... Oswego,s The Stafford opens its doors for tours o...arch 6, LAKE OSWEGO, Ore., Feb. 20 , Who/What: ...nity celebrates its grand opening with...imary School Choir and noted Musicians...
...ffordable dental/health care initiative to put an ...cy Dentist 24/7(TM),cutting edge health care model...nding its program, the first of its kind, by offer...ncing,affordable dental/health care available ever...
...ation, wealth play big part in downward trend, stu...Day News) -- Memory loss and thinking problems are...bly due to better education, personal wealth and c...older found the rate of cognitive impairment (the ...
...cientists know exposure to low levels of lead can ...guage impairments and vision loss, but a newly dis...men, according to a University of Houston professo...hile studying the effects of lead on the retina in...
...y finds enhanced alertness, mood in those who list... Feb. 20 (HealthDay News) -- Listening to music fo...t,s early recovery, according to Finnish researche... for a few hours a day showed better improvements ...
...ou may not be aware of it - they might not be awar...ight be slowing you down. , New research by Unive...r Dr. Tim Welsh says that regardless of their inte...ituation like a complex assembly line, said Welsh ...
Other Medicine News:Health News:Upscale Yet Affordable Housing Sets New Standard for Seniors 2Health News:Emergency Dentist 24/7(TM) Announces Worldwide Licensing Program 2Health News:Cognitive Impairment Declining in Older Adults 2Health News:Warning: Expert at UH adds obesity to side effects of lead exposure 2Health News:Music Therapy Improves Stroke Outcomes 2Health News:Who's slowing you down? 2
Gentamicin, 50 mg/ml
GENTAMICIN SULFATE, 1000X
...e is effective against gram positive and gram nega...ng with bacterial protein synthesis by binding to ...g concentration of 50 mg/L is generally non-toxic ...entler alternative to penicillin and steptomycin. ...
Gibco Gentamicin Reagent Solution (10 mg/ml) liquid
Medicine Products: